|
مقاله
|
Abstract
|
|
|
|
Title:
|
Long term outcomes of intravitreal bevacizumab for the treatment of aggressive posterior retinopathy of prematurity
|
|
Author(s):
|
Parvaresh M,Ghasemi Falavarjani KH,Sedaghat A,Astaraki A,Eshaghi A
|
|
Presentation Type:
|
Oral
|
|
Subject:
|
Posterior Segment and Uveitis
|
|
Others:
|
|
|
Presenting Author:
|
|
|
Name:
|
Arezoo Astaraki
|
|
Affiliation :(optional)
|
Iran University of Medical sciences.Eye Research Center
|
|
E mail:
|
dr.astaraki@gmail.com
|
|
Phone:
|
22676658
|
|
Mobile:
|
09122008967
|
|
|
|
|
Purpose:
|
To investigate the long term outcomes of intravitreal bevacizumab (IVB) in patients with aggressive posterior retinopathy of prematurity (ROP)
|
|
Methods:
|
All patients with aggressive posterior ROP treated with IVB during 2011-2012 were recruited and underwent evaluation under anesthesia in a cross-sectional study. Success of bevacizumab injection and the need for further procedures as well as peripheral vascularization of the retina was assessed.
|
|
Results:
|
Results: Mean follow up was 30.5±4.6 (22-38)months. From 123 eyes of 66 patients, 102(77.2%) eyes treated with a single IVB injection, 4(3%) eyes required the second IVB, 18(13.7%) eyes needed laser therapy and 8 eyes(6.1%) progressed to stage 4 ROP and required vitrectomy; 4 of them had attached retina after vitrectomy. After IVB injections, 61eyes (57.5%) had complete peripheral vascularization and 45 eyes (42.5%) showed peripheral avascularity.
|
|
Conclusion:
|
A major proportion of eyes with aggressive posterior ROP still had peripheral avascular area, 30 months after IVB injections.
|
|
Attachment:
|
|
|